An EORTC-ECSG phase I study of LU 79553 administered every 21 or 42 days in patients with solid tumours

Ahmad Awada, R. Thödtmann, Martine Piccart, J. Wanders, A. H. G. J. Schrijvers, I.-M. von Broen, Axel‐R. Hanauske

European Journal of Cancer · 2003 · 15 citations · 4 references

Concepts

References

4